Trialect

+ More Filters

Reset Filters

Specialty

Funding Organization

Funding Type

Eligible Country

Deadline

From

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Verified

RPB CAREER DEVELOPMENT AWARD

Research to Prevent Blindness

The RPB Career Development Award (CDA) helps RPB-supported ophthalmology Chairs support junior faculty who have demonstrated their potential for independent research. A detailed mentoring plan for the candidate is an important part of this award. This plan must be clearly defined in the Chair’s statement. Up to eight (8) Career Development Awards will be given.

RPB is partnering to co-fund one (1) award that focuses on artificial intelligence and/or data science.

The RPB / Tom Wertheimer Career Development Award in Data Science focuses on vision research using artificial intelligence and data science to gain new knowledge about sight-threatening conditions.
Where applicable, we strongly encourage the inclusion of diverse populations in proposed studies.
The RPB Career Development Award will not have a specific focus and is open to any topic within vision research.

Specialties

Ophthalmology

Eligibility Requirements

RPB-supported ophthalmology Chairs may nominate up to two candidates per department – one candidate for each award listed above -- whose primary appointment is in ophthalmology and whose primary lab space is under ophthalmology’s jurisdiction. Interim or acting Chairs cannot nominate a candidate for this award.
Candidates must hold a primary academic position up to and including Assistant Professor. Candidates must be either U.S. citizens or permanent residents (green card holder) by the application deadline. Previous recipients of this grant are ineligible.
The candidate’s first full-time ophthalmology faculty appointment must have been within three (3) years of the application deadline. Candidates must be full-time faculty in their nominating ophthalmology department by the application deadline.
At the application deadline, the candidate cannot currently have an R01 or an award through the DP1 mechanism or have been awarded an R01 or an award through a DP mechanism in the past as a Principal Investigator. Candidates with pending R01s or awards through a DP mechanism are eligible.
MDs and MD/PhDs must devote at least 50% of their time to research activities, with 60% desirable, as opposed to teaching or medical practice.
PhD faculty are no longer required to have a secondary appointment in a basic science or other relevant department prior to submission of the proposal; however, a secondary appointment is recommended. This does not apply to MDs or MD/PhDs.
Any previous RPB individual grants to the candidate must be fully spent and recognized as terminated by RPB before an individual researcher may apply for another RPB grant. This only applies to the candidate and not to the mentors and/or collaborators.

Eligible Countries:

United States

Sponsor Details

Sponsor Institute/Organizations: Research to Prevent Blindness

Address: 360 Lexington Ave., New York, NY10017-6528

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity